|
ZW800-1: The 1st Zwitterionic NIR Fluorophore for Cancer Imaging & Ureter Mapping
|
5R44CA210820-02
|
$989,401
|
$989,401
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$5,895
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$185,015
|
$185,015
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$30,836
|
$30,836
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Investigation of Epigenetic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$154,179
|
$154,179
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Targeting Metabolic Pathways in Bladder Cancer
|
ZIA BC 011741
|
$154,179
|
$154,179
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$30,836
|
$30,836
|
Agarwal, Piyush
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$61,672
|
$61,672
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$331,774
|
$331,774
|
Apolo, Andrea
|
CCR (NCI)
|
|
Targeting the MET pathway in urothelial carcinoma
|
ZIA BC 011594
|
$497,661
|
$497,661
|
Apolo, Andrea
|
CCR (NCI)
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$314,516
|
$314,516
|
Barchi, Joseph
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$107,655
|
Barr, Frederic
|
CCR (NCI)
|
|
Regulation of RNA biogenesis and function by RNA modifications
|
ZIA BC 011766
|
$1,075,766
|
$322,730
|
Batista, Pedro
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$330,596
|
$99,179
|
Beutler, John
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$3,561,926
|
$534,289
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers
|
ZIA BC 011095
|
$213,470
|
$213,470
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$396,445
|
$198,222
|
Bottaro, Donald
|
CCR (NCI)
|
|
Molecular biology of human polyomaviruses
|
ZIA BC 011090
|
$387,112
|
$193,556
|
Buck, Christopher
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$387,112
|
$270,978
|
Buck, Christopher
|
CCR (NCI)
|
|
Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells
|
ZIA BC 011777
|
$32,855
|
$6,571
|
Buxbaum, Nataliya
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,365,668
|
$68,283
|
Chinquee, Joseph
|
CCR (NCI)
|
|
Targeting mechanisms of radiation resistance
|
ZIA BC 011552
|
$472,836
|
$236,418
|
Citrin, Deborah
|
CCR (NCI)
|
|
Screening to identify protectors and mitigators of Radiation GI Syndrome
|
ZIA BC 011762
|
$472,836
|
$189,134
|
Citrin, Deborah
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
$742,855
|
Custer, Mary
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$61,417
|
$30,709
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$2,313,288
|
$462,657
|
Edelman, Daniel
|
CCR (NCI)
|
|
New Virus Identification
|
ZIA CP010150 10817
|
$1,179
|
$590
|
Engels, Eric
|
DCEG (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$244,114
|
$24,411
|
Figg, William
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$584,807
|
$35,088
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$804,110
|
$40,206
|
Gottesman, Michael
|
CCR (NCI)
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,978,942
|
$197,894
|
Gress, Ronald
|
CCR (NCI)
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,213,497
|
$121,350
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$865,192
|
$346,077
|
Hou, Steven
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$344,939
|
$17,247
|
Jones, Jennifer
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$379,286
|
$7,586
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$526,810
|
$26,341
|
Khan, Javed
|
CCR (NCI)
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$380,989
|
$76,198
|
Lewandoski, Mark
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$303,808
|
$30,381
|
Lim, Langston
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$440,152
|
$330,114
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$880,303
|
$660,227
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$880,303
|
$871,500
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$660,228
|
$429,148
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,540,531
|
$1,232,425
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Role of Shh in developmental patterning and growth of digit skeleton
|
ZIA BC 011118
|
$320,272
|
$32,027
|
Mackem, Susan
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$1,073,783
|
$214,757
|
Meier, Jordan
|
CCR (NCI)
|
|
Study of Hereditary Renal and Other Familial Syndromes
|
ZIA BC 010696
|
$244,544
|
$146,727
|
Merino, Maria
|
CCR (NCI)
|
|
microRNA Profiling in the Spectrum of Kidney Tumors
|
ZIA BC 011405
|
$122,272
|
$122,272
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$183,408
|
$86,202
|
Merino, Maria
|
CCR (NCI)
|
|
Renal and Baldder Cancer Case-Control study in Chile
|
ZIA CP010125 10462
|
$25,213
|
$25,213
|
Moore-Robert, Lee
|
DCEG (NCI)
|
Total relevant funding to Urinary System for this search: $17,394,762
|